ANMAT has approved a clinical trial in healthy individuals of a drug designed to control neuropathic pain. Dr. Marcelo Villar, Medical Director of Immunalgia Therapeutics and a CONICET researcher, spoke with Nota al Pie about this medical advancement with a national focus.